Insights

Gathering insights about Modula…

Similar companies to Modula

Envira Gallery
$1M

Modula Tech Stack

Media & News

Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump
Study to Deliver Insulin to Internal Testers Wearing Continuous Glucose Monitors SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion adult "almost-pumpers" diabetes market with user-friendly, affordable patch pumps, today announced Institutional Review Board ("IRB") approval to conduct an in-house study of its next-generation Pivot™ insulin delivery system using insulin on people with diabetes (the "Study"). Pursuant to U.S. Food and Drug Administration ("FDA") regulations, an IRB is a group that has been formally designated to review and monitor biomedical research involving human subjects.
Nov 17, 2025 | www.accessnewswire.com
Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance
-Targets $3 Billion "Almost-Pumper" Market with First Simplified and Removable/Replaceable Insulin Patch Pump - Aims to Improve Patient and Clinician Experience for the Care of Diabetes SAN DIEGO, CA / ACCESS Newswire / November 14, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company") today announced the 510(k) premarket submission of its next generation Pivot™ tubeless patch pump to the U.S. Food and Drug Administration (the "FDA"). The Company expects to commence the commercial launch of its Pivot pump in Q1 2026.
Nov 14, 2025 | www.accessnewswire.com
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
Key Highlights: Pivot Controller Line Validated: Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch. Pivot will be First Two-Part Tubeless Patch Pump: Pivot, a 3 milliliter removable patch pump, targets the $3 billion dollar market for adult "almost-pumpers" with its affordable, user-friendly, easy-to-learn design.
Nov 03, 2025 | www.accessnewswire.com
Modular Medical Announces Ongoing Progress to Obtain CE Mark
Key Highlights: Pivot continues to progress toward CE Mark certification in 2026 Stage 1 ISO Audit completed with Stage 2 planned for 1H2026 SAN DIEGO, CA / ACCESS Newswire / October 28, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery, today announced that it is continuing to progress toward CE Mark certification under the European Union Medical Device Regulation ("EU MDR 2017/745"). As part of this process, the Company is pleased to announce the successful completion of its Stage 1 ISO 13485:2016 audit, conducted by BSI, its Notified Body and Registrar.
Oct 28, 2025 | www.accessnewswire.com
Modular Medical Appoints David Bosshard to Lead its International Expansion for the Pivot Insulin Delivery System
-Seasoned Executive with Proven Track Record in International Pump Launches to Accelerate Global Adoption of User Friendly, Affordable Patch Pumps SAN DIEGO, CA / ACCESS Newswire / October 6, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion adult "almost-pumpers" diabetes market with easy to learn and operate user-friendly, affordable patch pumps, today announced the appointment of David Bosshard as Head of International Operations. With two decades of expertise in scaling similar tubeless insulin delivery systems across Europe and beyond, Mr.
Oct 06, 2025 | www.accessnewswire.com
Modular Medical Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
SAN DIEGO, CA / ACCESS Newswire / September 29, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 billion adult "almost-pumpers" diabetes market, today announced the exercise of certain existing warrants issued in May 2023 and March 2025 (the "Existing Warrants") at a reduced exercise price of $0.68 per share. The shares of common stock issuable upon exercise of the Existing Warrants are registered pursuant to effective registration statements on Form S-1 (file no.
Sep 29, 2025 | www.accessnewswire.com
Modular Medical Announces Completion of MODD1 Cartridge Production and Commencement of Pivot Conversion
-More than 6,000 MODD1 cartridges produced - Conversion to Pivot-ready manufacturing in preparation for product launch in 1Q26 SAN DIEGO, CA / ACCESS Newswire / August 26, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced that the MODD1 product cartridge production run has been completed and its manufacturing line is being converted to production for its Pivot product. "I want to congratulate our operational team for the successful validation of our MODD1 manufacturing process and production of human use cartridges," said Jeb Besser, CEO of Modular Medical.
Aug 26, 2025 | www.accessnewswire.com

Modula's Email Address Formats

Modula uses at least 1 format(s):

Modula Email Formats	Example	Percentage
First.Last@modula.com	John.Doe@modula.com	91%
Last@modula.com	Doe@modula.com	6%
FLast@modula.com	JDoe@modula.com	2%
Last.First@modula.com	Doe.John@modula.com	1%

Frequently Asked Questions

Where is Modula's headquarters located?

Modula's main headquarters is located at Via San Lorenzo, 41, Salvaterra, RE 42013, IT. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is Modula's stock symbol?

Modula is a publicly traded company; the company's stock symbol is MODD.

What is Modula's official website and social media links?

Modula's official website is modula.com and has social profiles on LinkedIn.

How much revenue does Modula generate?

As of October 2025, Modula's annual revenue is estimated to be $1M.

What is Modula's NAICS code?

Modula's NAICS code is 3339 - Other General Purpose Machinery Manufacturing.

How many employees does Modula have currently?

As of October 2025, Modula has approximately 561 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Cfo: G. C.Market Operations Director & Ceo: M. G.Customer Care Director: A. R.. Explore Modula's employee directory with LeadIQ.

What industry does Modula belong to?

Modula operates in the Automation Machinery Manufacturing industry.

What is Modula's email format?

Modula's email format typically follows the pattern of First.Last@modula.com. Find more Modula email formats with LeadIQ.

When was Modula founded?

Modula was founded in 1987.

Modula

Q: What is Modula's official website and social media links?

Modula's official website is modula.com. Modula has social profiles on LinkedIn.

Q: How many employees does Modula have currently?

Modula has approximately 561 employees.

Automation Machinery ManufacturingItaly501-1000 Employees

Modula è un'azienda produttrice di magazzini automatici verticali, con sede a Salvaterra di Reggio Emilia e a Lewiston, Maine.

Con i suoi sistemi di stoccaggio automatico consente di ridurre oltre il 90% dello spazio a terra, fornendo un'elevata velocità di picking e allo stesso tempo garantendo ergonomia agli operatori, tracciabilità dei prodotti, sicurezza delle merci.

Modula offre un'attività di consulenza per automatizzare i processi di logistica interna, massimizzando il valore del vostro prodotto, basandosi su soluzioni standard.

Modula fa parte del Gruppo System, attivo da oltre 45 anni e leader  nella fornitura di impianti per la ceramica e per il material handling con oltre mille impiegati e oltre 35 sedi in 25 paesi del mondo.

www.modula.com